Race and recurrence in women who undergo neoadjuvant chemotherapy for breast cancer

American Journal of Surgery

Volumn 205, Issue 4, 2013, Pages 397-401

  Howard Mcnatt, Marissa ^a   Lawrence, Julia ^a   Melin, Susan A ^a   Levine, Edward A ^a   Shen, Perry ^a   Stewart IV, John H ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Neoadjuvant chemotherapy; Race

Indexed keywords

ANTHRACYCLINE; AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; TAMOXIFEN; TAXANE DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CAUCASIAN; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODAL CHEMOTHERAPY; NEGRO; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RACE DIFFERENCE;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAXOIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875270522     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2013.01.009     Document Type: Article

References (20)

1. L. Ries, M. Eisner, and M. Kosary SEER Cancer Statistics Review, 1973-1999 2002 National Cancer Institute Bethesda, MD
2. L. Ries, M. Eisner, and M. Kosary SEER Cancer Statistics Review, 1975-2000 2003 National Cancer Institute; Bethesda, MD
3. L.A. Newman Breast cancer in African-American women Oncologist 10 2005 1 14
4. V.W. Chen, P. Correa, and R.J. Kurman Histological characteristics of breast carcinoma in blacks and whites Cancer Epidemiol Biomarkers Prev 3 1994 127 135
5. S.E. Weiss, P.I. Tarter, and S. Ahmed Ethnic differences in risk and prognostic factors for breast cancer Cancer 76 1995 268 274
6. S.A. Joslyn, and M.M. West Racial differences in breast carcinoma survival Cancer 88 2000 114 123
7. R.M. Elledge, G.M. Clark, and G.C. Chamness Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States J Natl Cancer Inst 86 1994 705 712
8. R.S. Sweeting, N. Klauber-DeMore, and M.O. Meyers Young women with locally advanced breast cancer who achieve breast conservation after neoadjuvant chemotherapy have a low local recurrence rate Am Surg 77 2011 850 855
9. B. Fisher, A. Brown, and E. Mamounas Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-18 J Clin Oncol 15 1997 2483 2493
10. P. Rastogi, S.J. Anderson, and H.D. Bear Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 J Clin Oncol 26 2008 778 785
11. H.D. Bear, S. Anderson, and R.E. Smith Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol 24 2006 2019 2202
12. S. Beriwal, G.F. Schwartz, and L. Komarnicky Breast-conserving therapy after neoadjuvant chemotherapy: long-term results Breast J 12 2006 159 164
13. L.A. Carey, C.M. Perou, and C.A. Livasey Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2006 2492 2502
14. C.M. Perou, T. Sorlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
15. T. Sorlie, C.M. Perou, and R. Tibshirani Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 2001 10869 10874
16. J.D. Brenton, L.A. Carey, and A.A. Ahmed Molecular classification and molecular forecasting of breast cancer. Ready for clinical application? J Clin Oncol 23 2005 7350 7360
17. M. DeBrot, R.M. Rocha, and F.A. Soares Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers Pathology 44 2012 303 312
18. W.A. Woodward, E.H. Huang, and M.D. McNeese African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy Cancer 107 2006 2662 2668
19. J.J. Weber, D.C. Mascarenhas, and L.S. Bellin Patient navigation and the quality of breast cancer care: an analysis of the Breast Cancer Care Quality Indicators Ann Surg Oncol 19 2012 3251 3256
20. Commission of Cancer, Cancer Program Standards 2012: Ensuring Patient-Centered Care, v1.0. Available at: http://www.facs.org/cancer/coc/ cocprogramstandards2012.pdf. Accessed January 7, 2013.